SI1257271T1 - Uporaba pramipeksola za zdravljenje zasvojenosti s tobakom/nikotinom - Google Patents

Uporaba pramipeksola za zdravljenje zasvojenosti s tobakom/nikotinom

Info

Publication number: SI1257271T1
Authority: SI; Slovenia
Prior art keywords: treament; pramipexole; tobacco; nicotine addiction; addiction
Prior art date: 2000-02-23

Application number

SI200130592T

Other languages

English (en)

Inventor

Robert C Marshall

Erik H F Wong

Philip F Vonvoigtlander

Original Assignee

Pharmacia & Upjohn Co Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-23

Filing date

2001-02-14

Publication date

2006-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22676121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1257271(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-02-14 Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc

2006-10-31 Publication of SI1257271T1 publication Critical patent/SI1257271T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Addiction (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicinal Preparation (AREA)

SI200130592T 2000-02-23 2001-02-14 Uporaba pramipeksola za zdravljenje zasvojenosti s tobakom/nikotinom SI1257271T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US18424200P	2000-02-23	2000-02-23
PCT/US2001/001232 WO2001062249A1 (en)	2000-02-23	2001-02-14	Use of pramipexole for the treatment of addictive disorders
EP01906557A EP1257271B1 (en)	2000-02-23	2001-02-14	Use of pramipexole for the treament of tobacco/nicotine addiction

Publications (1)

Publication Number	Publication Date
SI1257271T1 true SI1257271T1 (sl)	2006-10-31

Family

ID=22676121

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200130592T SI1257271T1 (sl)	2000-02-23	2001-02-14	Uporaba pramipeksola za zdravljenje zasvojenosti s tobakom/nikotinom

Country Status (24)

Country	Link
US (1)	US6410579B2 (sl)
EP (1)	EP1257271B1 (sl)
JP (1)	JP2003523387A (sl)
KR (1)	KR20030016230A (sl)
CN (1)	CN1396826A (sl)
AR (1)	AR027945A1 (sl)
AT (1)	ATE326967T1 (sl)
AU (1)	AU781358B2 (sl)
BR (1)	BR0107983A (sl)
CA (1)	CA2397874A1 (sl)
CO (1)	CO5261586A1 (sl)
DE (1)	DE60119896T2 (sl)
DK (1)	DK1257271T3 (sl)
ES (1)	ES2263586T3 (sl)
HK (1)	HK1053058A1 (sl)
MX (1)	MXPA02008184A (sl)
MY (1)	MY127739A (sl)
NZ (1)	NZ520974A (sl)
PE (1)	PE20011074A1 (sl)
PT (1)	PT1257271E (sl)
SI (1)	SI1257271T1 (sl)
TW (1)	TWI250016B (sl)
WO (1)	WO2001062249A1 (sl)
ZA (1)	ZA200206119B (sl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10041478A1 (de)	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
DE10138275A1 (de) *	2001-08-10	2003-02-27	Boehringer Ingelheim Pharma	Verbindungen zur Beseitigung der Anhedonie
MXPA04005572A (es)	2001-12-11	2004-12-06	Univ Virginia	Uso de pramipexol para tratamiento de esclerosis lateral amiotrofica.
US20040048779A1 (en) *	2002-05-06	2004-03-11	Erwin Schollmayer	Use of rotigotine for treating the restless leg syndrome
PA8578501A1 (es) *	2002-07-25	2005-02-04	Pharmacia Corp	Forma de dosificacion una vez al dia de pramipexol
DE10361258A1 (de)	2003-12-24	2005-07-28	Schwarz Pharma Ag	Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
JP2007518754A (ja) *	2004-01-22	2007-07-12	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	モノアミン神経伝達物質再取込みインヒビターとドーパミンアゴニストを含む医薬組成物
DE102004014841B4 (de)	2004-03-24	2006-07-06	Schwarz Pharma Ag	Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EA200700388A1 (ru) *	2004-08-13	2007-08-31	Бёрингер Ингельхайм Интернациональ Гмбх	Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ её изготовления и её применение
PT1781260E (pt) *	2004-08-13	2010-12-20	Boehringer Ingelheim Int	Formulação em comprimido de libertação prolongada contendo pramipexole ou um seu sal farmaceuticamente aceitável, um método para a preparação do mesmo e sua utilização
US20070134169A1 (en) *	2005-12-11	2007-06-14	Rabinoff Michael D	Methods for smoking cessation or alcohol cessation or other addiction cessation
US20090041844A1 (en) *	2006-02-10	2009-02-12	Boehringer Ingelheim International Gmbh	Modified Release Formulation
WO2007090883A1 (en) *	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Extended release formulation
US8518926B2 (en)	2006-04-10	2013-08-27	Knopp Neurosciences, Inc.	Compositions and methods of using (R)-pramipexole
CA2652251A1 (en)	2006-05-16	2007-11-29	Knopp Neurosciences, Inc.	Compositions of r(+) and s(-) pramipexole and methods for using the same
US8524695B2 (en)	2006-12-14	2013-09-03	Knopp Neurosciences, Inc.	Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US8519148B2 (en)	2007-03-14	2013-08-27	Knopp Neurosciences, Inc.	Synthesis of chirally purified substituted benzothiazole diamines
EP2203448B1 (de) *	2007-09-21	2011-06-22	Sanofi-Aventis	Phenothiazin-derivate mit doppelbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP2334185A4 (en)	2008-08-19	2011-09-21	Knopp Neurosciences Inc	COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
US9512096B2 (en)	2011-12-22	2016-12-06	Knopp Biosciences, LLP	Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
DE102012108398B4 (de)	2012-09-10	2014-05-22	Schott Ag	Kochfeld, Blende, Geräteeinhausung sowie Kamin- oder Ofensichtscheibe mit einem Hologramm und Verfahren zu dessen bzw. deren Herstellung, sowie Verwendung eines Substrats, auf welchem ein Phasenhologramm aufgebracht ist
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
HUE054185T2 (hu)	2013-07-12	2021-08-30	Knopp Biosciences Llc	Eozinofilek és/vagy bazofilek megemelkedett szintjének kezelése
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
US9763918B2 (en)	2013-08-13	2017-09-19	Knopp Biosciences Llc	Compositions and methods for treating chronic urticaria
WO2015023786A1 (en)	2013-08-13	2015-02-19	Knopp Biosciences Llc	Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3572485D1 (en)	1984-12-22	1989-09-28	Thomae Gmbh Dr K	Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de)	1988-12-22	1990-07-05	Boehringer Ingelheim Kg	Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) *	1989-09-11	1991-03-21	Boehringer Ingelheim Kg	Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit
DE3933738A1 (de)	1989-10-10	1991-04-11	Boehringer Ingelheim Kg	Neue verwendung von 2-aminothiazol-derivaten (tsh)
DE3937271A1 (de)	1989-11-09	1991-05-16	Boehringer Ingelheim Kg	Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4241013A1 (de)	1992-12-05	1994-06-09	Boehringer Ingelheim Kg	Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
US5650420A (en)	1994-12-15	1997-07-22	Pharmacia & Upjohn Company	Pramipexole as a neuroprotective agent
US6001861A (en)	1998-01-16	1999-12-14	Pharmacia & Upjohn Company	Use of pramipexole in the treatment of restless legs syndrome
WO2001022820A1 (en)	1999-09-30	2001-04-05	The General Hospital Corporation	Use of pramipexole as a treatment for cocaine craving

2001
- 2001-02-07 PE PE2001000131A patent/PE20011074A1/es not_active Application Discontinuation
- 2001-02-09 MY MYPI20010581A patent/MY127739A/en unknown
- 2001-02-14 DE DE60119896T patent/DE60119896T2/de not_active Revoked
- 2001-02-14 EP EP01906557A patent/EP1257271B1/en not_active Revoked
- 2001-02-14 KR KR1020027010951A patent/KR20030016230A/ko not_active Application Discontinuation
- 2001-02-14 ES ES01906557T patent/ES2263586T3/es not_active Expired - Lifetime
- 2001-02-14 MX MXPA02008184A patent/MXPA02008184A/es active IP Right Grant
- 2001-02-14 US US09/783,656 patent/US6410579B2/en not_active Expired - Fee Related
- 2001-02-14 BR BR0107983-2A patent/BR0107983A/pt not_active Application Discontinuation
- 2001-02-14 JP JP2001561315A patent/JP2003523387A/ja active Pending
- 2001-02-14 AU AU34454/01A patent/AU781358B2/en not_active Ceased
- 2001-02-14 CA CA002397874A patent/CA2397874A1/en not_active Abandoned
- 2001-02-14 AT AT01906557T patent/ATE326967T1/de not_active IP Right Cessation
- 2001-02-14 WO PCT/US2001/001232 patent/WO2001062249A1/en active IP Right Grant
- 2001-02-14 DK DK01906557T patent/DK1257271T3/da active
- 2001-02-14 PT PT01906557T patent/PT1257271E/pt unknown
- 2001-02-14 NZ NZ520974A patent/NZ520974A/en unknown
- 2001-02-14 CN CN01804037A patent/CN1396826A/zh active Pending
- 2001-02-14 SI SI200130592T patent/SI1257271T1/sl unknown
- 2001-02-20 AR ARP010100754A patent/AR027945A1/es unknown
- 2001-02-22 CO CO01014318A patent/CO5261586A1/es not_active Application Discontinuation
- 2001-02-23 TW TW090104177A patent/TWI250016B/zh not_active IP Right Cessation
2002
- 2002-07-31 ZA ZA200206119A patent/ZA200206119B/en unknown
2003
- 2003-07-24 HK HK03105334.1A patent/HK1053058A1/zh unknown

Also Published As

Publication number	Publication date
CN1396826A (zh)	2003-02-12
US20010041727A1 (en)	2001-11-15
WO2001062249A1 (en)	2001-08-30
CA2397874A1 (en)	2001-08-30
ATE326967T1 (de)	2006-06-15
NZ520974A (en)	2004-04-30
HK1053058A1 (zh)	2003-10-10
MY127739A (en)	2006-12-29
PE20011074A1 (es)	2001-10-04
AU781358B2 (en)	2005-05-19
BR0107983A (pt)	2003-01-28
AR027945A1 (es)	2003-04-16
PT1257271E (pt)	2006-09-29
EP1257271B1 (en)	2006-05-24
TWI250016B (en)	2006-03-01
EP1257271A1 (en)	2002-11-20
AU3445401A (en)	2001-09-03
CO5261586A1 (es)	2003-03-31
DE60119896D1 (de)	2006-06-29
DE60119896T2 (de)	2006-11-09
JP2003523387A (ja)	2003-08-05
KR20030016230A (ko)	2003-02-26
US6410579B2 (en)	2002-06-25
MXPA02008184A (es)	2002-11-29
DK1257271T3 (da)	2006-08-21
ZA200206119B (en)	2003-10-31
ES2263586T3 (es)	2006-12-16

Publication	Publication Date	Title
SI1257271T1 (sl)	2006-10-31	Uporaba pramipeksola za zdravljenje zasvojenosti s tobakom/nikotinom
EG22308A (en)	2002-12-31	Tobacco treatment
IL164204A0 (en)	2005-12-18	Tobacco having reduced nicotine and nitrosamines
IS2360B (is)	2008-05-15	Nýtt innöndunarduft sem inniheldur tíótrópíum
EG24478A (en)	2009-08-03	New inhalable powder containing tiotropium
IL154602A0 (en)	2003-09-17	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
IL159213A0 (en)	2004-06-01	Modifying nicotine and nitrosamine levels in tobacco
IL151890A0 (en)	2003-04-10	Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB0004531D0 (en)	2000-04-19	The treatment of respiratory diseases
IL147166A0 (en)	2002-08-14	Process for the adaptation of flavor mixtures
IL154290A0 (en)	2003-09-17	Stable pergolide mesylate and process for making same
IL151891A0 (en)	2003-04-10	Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002231283A1 (en)	2002-04-29	Use of p38 inhibitors for the treatment of smoke inhalation
NO20030717L (no)	2003-02-14	Forbindelser for behandling av avhengighetsforstyrrelser
GB2347607B (en)	2003-10-22	Papirosi cigarette filter
AU2001286875A1 (en)	2002-03-13	Bridged nicotine compounds for use in the treatment of cns pathologies
HK1053059A1 (zh)	2003-10-10	新用途
GB0125752D0 (en)	2001-12-19	Treatment of wet lung
FR2816173B1 (fr)	2002-12-27	Article pour fumeur de cigare
GB0012111D0 (en)	2000-07-12	Tobacco treatment
GB0005665D0 (en)	2000-05-03	Tobacco treatment
GB0104170D0 (en)	2001-04-11	Electronic tobacco & cigarette
IL152125A0 (en)	2003-05-29	Process for the manufacture of ecteinascidin derivatives
HU0000692D0 (en)	2000-04-28	Cigarette rescuer
GB0021725D0 (en)	2000-10-18	Cigarette smoke pacifier